Does Lipitor Interact with Pepcid Acutely?
No significant acute interaction occurs between Lipitor (atorvastatin) and Pepcid (famotidine). Both drugs are commonly co-prescribed without immediate pharmacokinetic conflicts, as famotidine—a histamine-2 receptor antagonist—does not substantially alter atorvastatin's CYP3A4 metabolism or absorption in short-term use.[1][2]
How Do These Drugs Work Together Mechanically?
Atorvastatin relies on CYP3A4 for metabolism in the liver, while famotidine primarily acts on H2 receptors in the stomach with minimal hepatic enzyme impact. In vitro and clinical data show no acute inhibition or induction, so plasma levels of either drug remain stable within hours of co-administration.[3]
What Happens with Short-Term or Single-Dose Use?
Acute dosing (e.g., one-time or daily for a few days) shows no clinically meaningful changes in atorvastatin exposure or famotidine efficacy. Steady-state studies confirm this, with no reports of elevated statin-related myopathy or acid suppression failure from immediate interplay.[1][4]
Any Long-Term Concerns if Used Together?
Chronic use is also safe per drug interaction databases, though rare case reports note minor GI effects unrelated to direct interaction. Monitor for additive stomach upset, but no dose adjustments are standard.[2][5]
Compared to Other Statins or Acid Reducers?
Unlike PPIs (e.g., omeprazole), which can slightly raise atorvastatin levels via CYP2C19 effects, famotidine avoids this. Other statins like rosuvastatin have even less interaction potential with H2 blockers.[3][6]
What Do Checkers and Databases Say?
- Lexicomp and Drugs.com rate it "no interaction."
- Micromedex lists it as low-risk.[1][2]
[1]: Drugs.com - Atorvastatin/Famotidine Interactions
[2]: Lexicomp - Lipitor and Pepcid Interaction
[3]: FDA Label - Lipitor (Atorvastatin)
[4]: PubMed - H2RA Effects on Statins
[5]: Micromedex - Famotidine Interactions
[6]: Clinical Pharmacology - PPI vs H2RA with Statins